CD40LG and COVID-19: Consistent with our observations, previous studies showed a lower prevalence of anti-SARS-CoV-2 IgM in COVID-19 patients than anti-SARS-CoV-2 IgG25,26, which might be due to lower assay sensitivity for IgM detection and its natural lower antigen affinity.